|
Volumn 26, Issue 4, 1999, Pages 456-466
|
Combination therapy of continuous venous infusion (CVI) of 5-FU and low dose consecutive cisplatin (CDDP), and the new oral anti-cancer drug S-1 for advanced gastro-intestinal cancer
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ANIMAL;
BONE MARROW;
CELL CYCLE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
GASTROINTESTINAL TUMOR;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
RAT;
REVIEW;
ADMINISTRATION, ORAL;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
CELL CYCLE;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FLUOROURACIL;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
INFUSIONS, INTRAVENOUS;
OXONIC ACID;
PYRIDINES;
RATS;
TEGAFUR;
|
EID: 0033087064
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (32)
|